World Health Organization. Child mortality and causes of death. WHO, https://www.who.int/gho/child_health/mortality/mortality_under_five_text/en/ (2020).

Pollard, A. J. & Bijker, E. M. A guide to vaccinology: from basic principles to new developments. Nat. Rev. Immunol. 21, 83–100 (2021).

Article  CAS  PubMed  Google Scholar 

Cao-Lormeau, V. M. et al. Guillain–Barré syndrome outbreak associated with Zika virus infection in French Polynesia: a case–control study. Lancet 387, 1531–1539 (2016).

Article  PubMed  PubMed Central  Google Scholar 

Patone, M. et al. Neurological complications after first dose of COVID-19 vaccines and SARS-CoV-2 infection. Nat. Med. 27, 2144–2153 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

& Barwick Eidex, R. Yellow Fever Vaccine Safety Working Group. History of thymoma and yellow fever vaccination.Lancet 364, 936 (2004).

Article  PubMed  Google Scholar 

Nath, A. Neurologic complications with vaccines: what we know, what we don’t, and what we should do. Neurology 101, 621–626 (2023).

Article  PubMed  PubMed Central  Google Scholar 

Polack, F. P. et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N. Engl. J. Med. 383, 2603–2615 (2020).

Article  CAS  PubMed  Google Scholar 

Perry, R. J. et al. Cerebral venous thrombosis after vaccination against COVID-19 in the UK: a multicentre cohort study. Lancet 398, 1147–1156 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Godlee, F., Smith, J. & Marcovitch, H. Wakefield’s article linking MMR vaccine and autism was fraudulent. BMJ 342, c7452 (2011).

Article  PubMed  Google Scholar 

Waugh, C. J., Willocks, L. J., Templeton, K. & Stevenson, J. Recurrent outbreaks of mumps in Lothian and the impact of waning immunity. Epidemiol. Infect. 148, e131 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baker, J. P. The pertussis vaccine controversy in Great Britain, 1974–1986. Vaccine 21, 4003–4010 (2003).

Article  PubMed  Google Scholar 

Larson, H. J., Gakidou, E. & Murray, C. J. L. The vaccine-hesitant moment. N. Engl. J. Med. 387, 58–65 (2022).

Article  CAS  PubMed  Google Scholar 

Knipe, D. M., Levy, O., Fitzgerald, K. A. & Muhlberger, E. Ensuring vaccine safety. Science 370, 1274–1275 (2020).

Article  CAS  PubMed  Google Scholar 

Folegatti, P. M. et al. Safety and immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2: a preliminary report of a phase 1/2, single-blind, randomised controlled trial. Lancet 396, 467–478 (2020).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ramasamy, M. N. et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. Lancet 396, 1979–1993 (2021).

Article  PubMed  Google Scholar 

Jackson, L. A. et al. An mRNA vaccine against SARS-CoV-2 — preliminary report. N. Engl. J. Med. 383, 1920–1931 (2020).

Article  CAS  PubMed  Google Scholar 

Voysey, M. et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK. Lancet 397, 99–111 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Scully, M. et al. Pathologic antibodies to platelet factor 4 after ChAdOx1 nCoV-19 vaccination. N. Engl. J. Med. 384, 2202–2211 (2021).

Article  CAS  PubMed  Google Scholar 

Candore, G. et al. Comparison of statistical signal detection methods within and across spontaneous reporting databases. Drug. Saf. 38, 577–587 (2015).

Article  CAS  PubMed  Google Scholar 

Lazarus, R. et al. Safety and immunogenicity of concomitant administration of COVID-19 vaccines (ChAdOx1 or BNT162b2) with seasonal influenza vaccines in adults in the UK (ComFluCOV): a multicentre, randomised, controlled, phase 4 trial. Lancet 398, 2277–2287 (2021).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Verani, J. R. et al. Case–control vaccine effectiveness studies: preparation, design, and enrollment of cases and controls. Vaccine 35, 3295–3302 (2017).

Article  PubMed  PubMed Central  Google Scholar 

Farrington, P. The self-controlled case series method and covid-19. BMJ 377, o625 (2022).

Article  PubMed  Google Scholar 

Minor, P. D. Live attenuated vaccines: historical successes and current challenges. Virology 479–480, 379–392 (2015).

Article  PubMed  Google Scholar 

Norrby, E. Yellow fever and Max Theiler: the only Nobel Prize for a virus vaccine. J. Exp. Med. 204, 2779–2784 (2007).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Baicus, A. History of polio vaccination. World J. Virol. 1, 108–114 (2012).

Article  PubMed  PubMed Central  Google Scholar 

Mangtani, P. et al. Protection by BCG vaccine against tuberculosis: a systematic review of randomized controlled trials. Clin. Infect. Dis. 58, 470–480 (2014).

Article  PubMed  Google Scholar 

Poyhonen, L., Bustamante, J., Casanova, J. L., Jouanguy, E. & Zhang, Q. Life-threatening infections due to live-attenuated vaccines: early manifestations of inborn errors of immunity. J. Clin. Immunol. 39, 376–390 (2019).

Article  PubMed  PubMed Central  Google Scholar 

Reno, E. et al. Prevention of yellow fever in travellers: an update. Lancet Infect. Dis. 20, e129–e137 (2020).

Article  CAS  PubMed  Google Scholar 

Garske, T. et al. Yellow Fever in Africa: estimating the burden of disease and impact of mass vaccination from outbreak and serological data. PLoS Med. 11, e1001638 (2014).

Article  PubMed  PubMed Central  Google Scholar 

Gianchecchi, E., Cianchi, V., Torelli, A. & Montomoli, E. Yellow fever: origin, epidemiology, preventive strategies and future prospects. Vaccines 10, 372 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Staples, J. E., Gershman, M., Fischer, M. & Centers for Disease Control and Prevention. Yellow fever vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm. Rep. 59, 1–27 (2010).

PubMed  Google Scholar 

de Abreu, A. J. L., Cavalcante, J. R., de Araujo Lagos, L. W., Caetano, R. & Braga, J. U. A systematic review and a meta-analysis of the yellow fever vaccine in the elderly population. Vaccines 10, 711 (2022).

Article  PubMed  PubMed Central  Google Scholar 

Kitchener, S. Viscerotropic and neurotropic disease following vaccination with the 17D yellow fever vaccine, ARILVAX®. Vaccine 22, 2103–2105 (2004).